Elicio Therapeutics Inc. (ELTX) — Cash Flow Quality Index
Elicio Therapeutics Inc. (ELTX) has a Cash Flow Quality Index of -0.96x as of December 2021. Operating cash flow of $-14.36 Million is below net income of $14.89 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Elicio Therapeutics Inc. (ELTX) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Elicio Therapeutics Inc. Cash Flow Quality Index (2012–2013)
Historical Cash Flow Quality Index for Elicio Therapeutics Inc. across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ELTX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Elicio Therapeutics Inc. (2012–2013)
Year-by-year earnings quality comparison for Elicio Therapeutics Inc.. For live market cap and the full company financial profile, see Elicio Therapeutics Inc. market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2013 | 2.99x | $1.89 Million | $632.24K | ▼ -13.7% |
| 2012 | 3.47x | $1.07 Million | $307.30K | — |